Hubert C. Chen

Insider Reports History

Location
San Diego, CA
Signature
/s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hubert C. Chen:

Company Role Class Num Shares Value Price $ Report Date Ownership
Forte Biosciences, Inc. President and Chief Scientific Officer Common Stock 93,405 $76,751 $0.8217 01 Jan 2024 Direct
Forte Biosciences, Inc. President and Chief Scientific Officer Restricted Stock Units 90,000 $73,953 $0.8217 01 Jan 2024 Direct
Metacrine, Inc. Chief Medical Officer Common Stock 3,289 $1,546 $0.4700 20 May 2021 Direct

Insider Reports Filed by Hubert C. Chen

Symbol Company Period Transactions Value $ Form Type Role Filing Time
FBRX Forte Biosciences, Inc. 01 Jan 2024 3 -$2,525 4 President and Chief Scientific Officer 03 Jan 2024, 16:04
FBRX Forte Biosciences, Inc. 01 Oct 2023 3 -$1,717 4 President and Chief Scientific Officer 03 Oct 2023, 16:29
FBRX Forte Biosciences, Inc. 31 Jul 2023 1 +$75,000 4 President and Chief Scientific Officer 02 Aug 2023, 17:58
FBRX Forte Biosciences, Inc. 01 Jul 2023 3 -$2,697 4 President and Chief Scientific Officer 05 Jul 2023, 16:08
FBRX Forte Biosciences, Inc. 01 Apr 2023 3 -$2,619 4 President and Chief Scientific Officer 04 Apr 2023, 20:17
FBRX Forte Biosciences, Inc. 25 Feb 2023 1 $0 4 President and Chief Scientific Officer 27 Feb 2023, 19:15
FBRX Forte Biosciences, Inc. 07 Jun 2022 1 $0 4 President and Chief Scientific Officer 08 Jun 2022, 16:24
FBRX Forte Biosciences, Inc. 07 Jun 2022 0 $0 3 President and Chief Scientific Officer Exhibit 24 - Power of Attorney 08 Jun 2022, 16:22
/report/000120919121034595-chen-hubert-c-2021-05-20 Metacrine, Inc. 20 May 2021 1 +$11,840 4 Chief Medical Officer 20 May 2021, 18:54